Guelph, April 4, 2018 – Glysantis Inc. today announced that it has been selected as a finalist in the RESI at MaRS Toronto Innovation Challenge. Glysantis Inc. will be one of 30 early-stage biotech, med-tech and digital health startups to showcase a poster vying for “RESI bucks” given to attendees to “invest” in the most… Read more Glysantis Inc. Selected as a Finalist in RESI Toronto Innovation Challenge at Toronto Health Innovation Week 2018.
Guelph, Jan 3, 2018 – Glysantis™ Inc. today announced that it will present at Biotech Showcase™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square. Ricky Ghoshal, Sr. Business Development Associate, will present at the Biotech Showcase™ as follows: Date: Wednesday, January 10, 2018… Read more Glysantis™ Inc. to Present at the Biotech Showcase™ Annual Conference on January 10, 2018
On Thursday, September 28th Mirexus Biotechnologies hosted a ground-breaking ceremony to celebrate the commencement of construction of its new manufacturing and research facility in Guelph. The building will include expanded lab space and offices, and most importantly a first-generation factory, designed to produce 16T / year of NanoDendrix™ – Mirexus’ safe & natural nanomaterial. The… Read more Mirexus Biotechnologies celebrated ground-breaking for new manufacturing facility